| Literature DB >> 35900778 |
Gülnihan Üstündağ1, Gonca Özyurt2, Ahu Kara Aksay1, Aslıhan Şahin1, Yıldız Ekemen Keleş1, Yusuf Öztürk3, Pınar Şamlıoğlu4, Kayı Eliaçık5, Dilek Yılmaz Çiftdoğan.
Abstract
ABSTRACT: COVID-19 has affected individuals of all age groups, both physically and mentally. We aimed to determine anxiety and depression in children diagnosed with COVID-19. Fifty children aged 8 to 18 years diagnosed with COVID-19 were included in the study. The children were evaluated the revised Child Anxiety and Depression Scale, STAI form TX-I (state anxiety inventory), and STAI form TX-II (trait anxiety inventory). Child Sleep Habits Questionnaire was applied for one of the parents according to three different periods. The periods were established as before the pandemic, during the illness-quarantine process, and after the quarantine. We observed the highest scores for depression-anxiety and the poorest sleep quality during the quarantine period. The scores for depression-anxiety were lower, and sleep quality scores were higher in the prepandemic period compared with after the quarantine period. Measures should be taken to protect mental health for children with COVID-19.Entities:
Mesh:
Year: 2022 PMID: 35900778 PMCID: PMC9351506 DOI: 10.1097/NMD.0000000000001513
Source DB: PubMed Journal: J Nerv Ment Dis ISSN: 0022-3018 Impact factor: 1.899
FIGURE 1Summary of the survey results of the children diagnosed with COVID-19.
Comparison of the Depression and Anxiety Levels of the Patients Diagnosed With COVID-19 in Prepandemic, Quarantine, and Postdisease Periods
| RCADS | P0 (Prepandemic) | P1 (Quarantine) | P2 (Postdisease) |
| |||
|---|---|---|---|---|---|---|---|
| Separation anxiety disorder | 5.12 ± 3.05 | 8.20 ± 5.13 | 6.56 ± 3.82 | <0.001 | <0.001 | <0.001 | <0.001 |
| Social phobia | 7.71 ± 4.37 | 11.98 ± 6.82 | 8.83 ± 5.13 | <0.001 | <0.001 | 0.008 | <0.001 |
| Obsessive compulsive disorder | 3.72 ± 2.07 | 7.58 ± 3.70 | 5.76 ± 2.98 | <0.001 | <0.001 | <0.001 | <0.001 |
| Panic disorder | 5.47 ± 3.34 | 11.49 ± 6.62 | 7.69 ± 4.81 | <0.001 | <0.001 | <0.001 | <0.001 |
| Generalized anxiety disorder | 3.92 ± 2.23 | 8.65 ± 4.15 | 6.36 ± 3.55 | <0.001 | <0.001 | <0.001 | <0.001 |
| Major depressive disorder | 6.10 ± 3.33 | 13.14 ± 6.66 | 8.53 ± 4.68 | <0.001 | <0.001 | <0.001 | <0.001 |
As triple variables, it was evaluated with the Friedman test.
Evaluated by the Wilcoxon test.
Comparison of the STAI-State and Trait Anxiety Inventory of the Patients Diagnosed With COVID-19 in Prepandemic, Quarantine, and Postdisease Periods
| P0 (Prepandemic) | P1 (Quarantine) | P2 (Postdisease) |
| ||||
|---|---|---|---|---|---|---|---|
| STAI-state anxiety inventory | 32.88 ± 7.16 | 38.90 ± 11.24 | 35.14 ± 8.43 | <0.001 | <0.001 | <0.001 | 0.008 |
| STAI-trait anxiety inventory | 33.28 ± 8.68 | 38.98 ± 9.58 | 34.98 ± 5.52 | <0.001 | <0.001 | <0.001 | <0.001 |
As triple variables, it was evaluated with the Friedman test.
Evaluated by the Wilcoxon test.
Comparison of the Sleep Habits of the Patients Diagnosed With COVID-19 in Prepandemic, Quarantine, and Postdisease Periods
| CSHQ | P0 (Prepandemic) | P1 (Quarantine) | P2 (Postdisease) |
| |||
|---|---|---|---|---|---|---|---|
| Bedtime resistance | 9.05 ± 3.12 | 11.18 ± 3.67 | 9.86 ± 3.29 | <0.001 | <0.001 | <0.001 | <0.001 |
| Sleep onset delay | 1.62 ± 0.75 | 2.20 ± 0.67 | 1.78 ± 0.91 | <0.001 | <0.001 | 0.005 | <0.001 |
| Sleep duration | 4.02 ± 1.41 | 5.50 ± 1.59 | 4.34 ± 1.88 | <0.001 | <0.001 | 0.008 | <0.001 |
| Sleep anxiety | 7.04 ± 2.10 | 7.56 ± 2.56 | 7.34 ± 2.42 | <0.001 | <0.001 | 0.006 | 0.009 |
| Night wakings | 3.84 ± 1.25 | 5.46 ± 1.64 | 4.26 ± 1.89 | <0.001 | <0.001 | 0.006 | <0.001 |
| Parasomnias | 8.16 ± 2.22 | 10.72 ± 2.94 | 8.66 ± 3.07 | <0.001 | <0.001 | 0.005 | <0.001 |
| Sleep-disordered breathing | 3.42 ± 1.07 | 3.56 ± 1.28 | 3.42 ± 1.12 | 0.030 | 0.008 | 0.998 | 0.102 |
| Daytime sleepiness | 13.73 ± 2.82 | 14.42 ± 2.83 | 14.13 ± 2.87 | <0.001 | <0.001 | 0.011 | 0.026 |
As triple variables, it was evaluated with the Friedman test.
Evaluated by the Wilcoxon test.